The impact of vascular anastomosis time on early kidney transplant outcomes by Karim Marzouk et al.
TRANSPLANTATION 
RESEARCH
Marzouk et al. Transplantation Research 2013, 2:8
http://www.transplantationresearch.com/content/2/1/8RESEARCH Open AccessThe impact of vascular anastomosis time on early
kidney transplant outcomes
Karim Marzouk2, Joseph Lawen3, Ian Alwayn4 and Bryce A Kiberd1,4*Abstract
Background: Most studies have found cold ischemic time to be an important predictor of delayed graft function in
kidney transplantation. Relatively less is known about the warm time associated with vascular anastomosis and early
outcomes.
Methods: A retrospective cohort of 298 consecutive solitary deceased donor kidney recipients from January 2006
to August 2012 was analyzed to examine the association between anastomosis time and delayed graft function
(need for dialysis) and length of hospital stay.
Results: Delayed graft function (DGF) was observed in 56 patients (18.8%). The median anastomosis time was 30
minutes (interquartile range 24, 45 minutes). Anastomosis time was independently associated with DGF in a
multivariable, binary logistic regression analysis (odds Ratio (OR) 1.037 per minute, 95% CI 1.016, 1.057, P = 0.001).
An anastomosis time >29 minutes was also associated with a 3.5 fold higher (OR 3.5, 95% CI 1.6, 7.3, P = 0.001) risk
of DGF. Median days in hospital was 9 (interquartile range 7, 14 days). Every 5 minutes of longer anastomosis time
(0.20 days per minute, 95% CI 0.13, 0.27, P <0.001) was associated with 1 extra day in hospital in a multivariable
linear regression model. An anastomosis time >29 minutes was associated with 3.8 (95% CI 1.6, 6.0, P <0.001) more
days in hospital.
Conclusion: Anastomosis time may be an underappreciated but modifiable variable in dictating use of hospital
resources. The impact of anastomosis time on longer term outcomes deserves further study.
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Over the last two decades cold ischemic time (CIT) has
been found to be an important independent risk factor
for delayed graft function (DGF) in deceased donor kid-
ney transplantation [1-4]. DGF is also associated with in-
ferior graft survival and function [1-3]. All supporting
evidence for the adverse events associated with DGF is
derived from cohort studies. DFG likely results in longer
stays in hospital and additional resource use (dialysis).
Surprisingly there are few studies examining the effects
of warm ischemic time (WIT) on DGF [5,6]. The* Correspondence: Bryce.kiberd@dal.ca
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reproduction in any medium, provided the orimportance of WIT has become a hot area of research in
Urology especially with greater use of partial nephrec-
tomy for cancer surgery [7,8]. There is also recent infor-
mation that long WITs may reduce graft survival in live
donor kidney transplantation [9].
By definition there are two WITs. The first relates to
organ procurement and the second relates to the vascu-
lar anastomosis time (AT) in the recipient. The purpose
of this study is to examine the second warm time or the
AT during the recipient operation and examine whether
this contributes to delayed graft function.Methods
Consecutive deceased donor organ transplant recipients
of solitary kidneys were identified in the Program data-
base from January 2006 until August 2012. Combined
organ and living donor transplant procedures were ex-
cluded. Data were extracted retrospectively from ourl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Population descriptors (n = 298)
Descriptor Value
Age, years, mean ± SD 51 ± 13
Gender, male, number (%) 181 (60.7%)
Regraft, number (%) 29 (9.0%)
Diabetes mellitus, number (%) 69 (23%)
End-stage renal disease
Polycystic kidney disease, number (%) 55 (19%)
Glomerulonephritis, number (%) 85 (29%)
Diabetes mellitus, number (%) 50 (17%)
Recipient weight, kg, mean ± SD 78 ± 17
Recipient body mass index, kg/m2, mean ± SD 28 ± 5
Blood transfusion, never, number (%) 205 (69%)
Human leukocyte antigen mismatch, mean ± SD 4.1 ± 1.4
Dialysis duration, days, median (IQR) 819 (419, 1462)
Calculated panel reactive antibody, %, median (IQR) 0 (0, 8)
Cold ischemic time, hours, median (IQR) 12 (8, 16)
Anastamosis time, minutes, median (IQR) 30 (24, 45)
Donation after circulatory death, number (%) 16 (5.4%)
Donor cause of death
Anoxia, number (%) 24 (8%)
Cerebrovascular event, number (%) 189 (62%)
Donor age years, mean ± SD 47 ± 17
Donor male, number (%) 135 (45%)
Donor weight kg, mean ± SD 76 ± 19
Donor body mass index kg/m2, mean ± SD 27 ± 6
Donor creatinine μmol/L, mean ± SD 67 ± 31
Delayed graft function, number (%) 56 (18.8%)
Days in hospital, days, median (IQR) 9 (7, 14)
Creatinine day 7, μmol/L, median (IQR) 168 (125, 314)
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January 2006. Approval for this retrospective study was
obtained from our institution’s research ethics board.
All patients received induction with either basiliximab
or antithymocyte globulin (ATG) and all received pre-
operative methylprednisolone (500 mg) intravenously.
ATG was reserved for those who were repeat transplant
recipients, those who received organs from deceased
cardiac donors, and those with a calculated panel react-
ive antibody level >20%. Post-operative patients received
oral tacrolimus, mycophenolate, and prednisone. All pa-
tients were treated with sulfamethoxazole-trimethoprim
for pneumocystis prophylaxis and oral ranitidine for
gastrointestinal ulcer prophylaxis. For patients on a
proton pump inhibitor pre transplant, this agent was
continued in place of the ranitidine. Cytomegalovirus
(CMV) prophylaxis with valganciclovir was used in
CMV-negative recipients receiving CMV-positive organs
and CMV-positive recipients receiving ATG. All patients
received subcutaneous heparin for venous thrombo-
embolism prophylaxis.
Data extracted included recipient age, gender, body
mass index (BMI), weight, calculated panel reactive anti-
bodies (cPRA), human leukocyte antigen mismatch
(HLA MM), cause of end-stage renal disease (ESRD),
diabetes mellitus status at transplantation, duration of
dialysis pretransplantation, blood transfusion pre trans-
plantation, CIT, donor cause of death, donor age, gender,
BMI, weight, terminal creatinine, and donation after cir-
culatory death (DCD) versus neurologic death. Since
over 96% of the population was non-black, race was not
included in the analysis. AT was defined as the time be-
tween the end of the cooling period to successful renal
artery anastomosis and perfusion of the donor kidney. In
the few patients requiring reoperation the cross-clamped
warm time of the second operation was included. The
first warm time from the procurement process was not
included. This first warm time is generally much shorter
than the second [5]. The outcomes were DGF (defined
as need for dialysis post transplantation within the first
week), days in hospital, and recipient serum creatinine
level at day 7.
Data are presented as mean ± standard deviation for
continuous variables with a normal distribution and me-
dian and interquartile range (IQR) for those variables
not distributed normally. Differences in AT between
groups with or without delayed graft function were
tested by the Kruskal-Wallis test. Variables associated
with DGF were examined by binary logistic regression
analysis. Variables associated with days in hospital and
serum creatinine on day 7 were examined by linear re-
gression analysis. Variables examined for statistical asso-
ciations with outcomes were recipient age, gender, BMI,
weight, cPRA, HLA MM, duration of dialysis, bloodtransfusion pre transplantation (never versus yes), dia-
betes mellitus status at transplantation, CIT, donor cause
of death (anoxia versus other, and cerebrovascular event
versus other), donor age, gender, weight, BMI, terminal
serum creatinine, DCD, and AT. Variables that were sig-
nificant at P <0.1 in a univariable analysis were included
into the multivariable models. Overall significance was
assumed at the P = 0.05 level (two-sided). Statistical ana-
lysis was performed using IBM SPSS Statistics software
version 20.0 (New York, NY, USA).
Results
In this retrospective cohort of 307 consecutive deceased
donor solitary kidney transplant recipients in the data-
base, ATs were available in 298 subjects. The nine (2.9%)
missing subjects were excluded from the analysis. Of the
remaining 298 patients, 56 (18.8%) had DGF. Character-
istics of the patients are shown in Table 1. Figure 1
Figure 1 Histogram of anastomosis times. Figure 3 Influence of anastomosis time on days in hospital.
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tribution is significantly skewed the median is the more
appropriate descriptor (median 30 minutes, IQR 24, 45
minutes). Figure 2 (box and whisker plot) shows that pa-
tients experiencing DGF had significantly longer ATs.
AT was independently associated with DGF in the binary
logistic regression analysis (odds ratio (OR) 1.037 per
minute, 95% CI 1.016, 1.057, P = 0.001). Other variables
that were significant in the model were DCD (OR 11,
95% CI, 3.3, 34, P <0.001), donor BMI (OR 1.06 per kg/
m2, 95% CI, 1.003, 1.12, P = 0.041), and dialysis duration
pre transplantation (OR 1.001 per day, 95% CI, 1.000,
1.002, P <0.001). Diabetes mellitus, donor sex, and re-
peat transplants were included in the multivariable
model (P <0.10 in the univariable model) but were not
independently significant. In a separate multivariable
model, an AT >29 minutes was associated with an in-
creased risk of DGF (OR 3.5, 95% CI 1.6, 7.3, P = 0.001).Figure 2 Delayed graft function (1 = yes, 0 = no) and
anastomosis (warm) time.The median days in hospital was 9 (IQR 7, 14 days).
Figure 3 shows the relationship between AT and days in
hospital (r = 0.32, P <0.001). AT (B coefficient 0.20 days
per minute AT, 95% CI, 0.13, 0.27, P <0.001) was associ-
ated with longer stays in hospital in the multivariable
linear regression analysis model. Therefore every 5 mi-
nutes of longer AT was associated with one extra day in
hospital. Other significant covariables were DCD
(B coefficient 11 days, 95% CI, 7, 16, P <0.001), dialysis
duration pre transplantation (B coefficient 0.002 days
per day, 95% CI, 0.001, 0.003, P = 0.001) and donor sex
(B coefficient 3.5 days for male, 95% CI, 1.4, 5.6,
P = 0.001). Recipient age, diabetes mellitus, donor age,
and repeat transplants were included in the multivari-
able model (P <0.10 in the univariable model) but were
not independently significant. In a separate multivariable
model an AT >29 minutes was associated with 3.8 days
(95% CI 1.6, 6.0, P <0.001) longer in hospital.
The median serum creatinine on day 7 was 168 μmol/L
(IQR 125, 314). AT (B coefficient 4.0 μmol/L per minute
AT, 95% CI, 2.1, 5.0, P <0.001) was associated with higher
day 7 creatinine levels. Other significant factors in the
multivariable model were donor terminal serum creatinine
(B coefficient 1.8 μmol/L per μmol/L, 95% CI, 1.04, 2.5,
P = 0.001) and DCD (B coefficient 312 μmol/L, 95% CI,
213, 411, P <0.001). Recipient sex, recipient weight, dia-
betes mellitus, and donor BMI were included in the multi-
variable model (P <0.10 in the univariable model) but
were not independently significant. An AT >29 minutes
was associated with a higher creatinine at day 7 (B coeffi-
cient 75 μmol/L, 95% CI, 30, 121, P <0.001).
Discussion
AT may be an underappreciated but modifiable variable
in dictating use of hospital resources. There were signifi-
cant increases in both need for dialysis and length of
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nutes was associated with particularly worse outcomes.
The study also shows that the serum creatinine was
higher 7 days after transplantation with longer ATs, con-
sistent with slower recovery of kidney function.
Surprisingly few studies have examined WIT as a co-
variate in studies of delayed graft function or survival. In
a normogram to predict DGF, Irish et al. identified WIT
as a significant variable but the overall effect was small
[6]. The reasons why this study demonstrated a greater
effect with AT is not clear since most of the variables in-
cluded in the DGF normogram were also considered in
this study. The DGF normogram was examined in one
center and found to have limited accuracy [10]. In
Grossberg’s study, transplant recipients with and without
DGF had DGF normogram scores that were not signifi-
cantly different. DGF as defined in this paper and by
Irish et al. may not be the best predictor of later graft
function [6]. Moore et al. found the DGF normogram to
be less predictive of later kidney function at 1 year than
other measures. Creatinine at day 5, and to a similar ex-
tent creatinine at day 7 post kidney transplantation were
predictive of later function at 1 year [11]. In a single
center study from the Netherlands of over 1,000 solitary
deceased and live donor kidney recipients transplanted
between 1981 and July 2000, neither the first nor second
warm time was significantly associated with outcomes
[5]. However, a more recent study from the same coun-
try in live donor kidney recipients found that prolonged
warm times (>45 minutes) were associated with a >3-
fold higher risk of graft loss [9]. Most research has
focused on CIT, preservation solutions or the use of
machine perfusion pumps to avoid reperfusion injury
and DGF and these do not directly address the AT [12].
Even the large recent randomized trials such as the
international trial on the use of machine pumps to pre-
vent DGF or recent cohort trials examining risk factors
for DGF did not include WIT in their analysis as a po-
tential confounder [4,13].
There is a growing body of evidence in the urological lit-
erature that WIT in partial nephrectomy is detrimental and
there should be no reason why these adverse effects associ-
ated with WIT would be irrelevant in kidney transplant-
ation [7,8]. Consistent with a debate in the urologic
literature, there may not be a threshold effect and every mi-
nute may count [7]. In a recent publication examining the
effect of WIT in a cohort undergoing partial nephrectomy
of a solitary kidney, it was found that each minute of warm
ischemia was associated with a 6% increased risk of acute
kidney injury and 4% increased risk of new onset ESRD
[14]. Clearly some prolonged times are unavoidable, espe-
cially in those with multiple vessels that have significant
atherosclerosis or that require re-exploration. Minimizing
warm time by back table surgery would also be re-commended. Recognizing that pursuing speed should not
impact the quality of anastomosis, increasing the awareness
of this issue amongst surgeons may be sufficient to improve
ATs. It might be necessary to include more simulation and
skills laboratory time for trainees to gain adequate expertise
prior to performing anastomoses in clinical practice.
There are significant limitations to this study. This
was retrospective and single center, and long-term ef-
fects on graft or patient survival were not examined be-
cause of the low event rates (98% patient and 96% graft
survival at one year). Given the growing body of clinical
and experimental evidence that acute ischemic kidney
injury is associated with later progressive chronic kidney
disease in the non-transplant setting, a more detailed
analysis of larger registries should be undertaken
[15-17]. If an association between greater AT and worse
long-term graft survival is observed, then there would be
even greater interest in testing early pharmacologic
interventions or devising better means to minimize
the warm time. A number of strategies have been tes-
ted experimentally and in ongoing clinical trials
(clinicaltrials.gov) to prevent ischemia-reperfusion injury.
In addition to previously studied interventions such as
spironolactone in animals, therapies to prevent leukocyte
recruitment and inflammation (NCT00248040), cytokine
damage (NCT00298168) and the use of small interfering
RNAs (NCT00802347) to prevent renal injury may hold
promise [17,18].
In summary, this study highlights the importance of
the anastomosis time in kidney transplantation on short-
term outcomes that may impact long-term outcomes.
More significantly this event may be modifiable, or po-
tentially an area and time for other types of intervention.
Abbreviations
AT: Anastomosis time; ATG: Antithymocyte globulin; BMI: Body mass index;
CIT: Cold ischemic time; CMV: Cytomegalovirus; cPRA: Calculated panel
reactive antibody; DCD: Donation after circulatory death; DGF: Delayed graft
function; DIH: Days in hospital; ESRD: End-stage renal disease;
GN: Glomerulonephritis; HLA MM: Human leukocyte antigen mismatch;
PCKD: Polycystic kidney disease; OR: Odds ratio; WIT: Warm ischemic time;
IQR: Interquartile range.
Competing interests
None of the authors declare any funding for this study or competing
interests. However JL, IA and BK are participating in a contract research study
with Quark Pharmaceuticals.
Authors’ contributions
KM collected data and helped draft the manuscript. JL co-designed the
study, and critically appraised the analysis and significance. IA critically
appraised the analysis and significance. BK co-designed the study, collected
and analyzed data, and assisted in manuscript preparation. All authors read
and approved the final manuscript.
Acknowledgement
There were no external sources of funding for this study.
Author details
1Department of Medicine, Dalhousie University, 5082 Dickson Building,
Queen Elizabeth Health Sciences-VG site, 5280 University Ave, Halifax NS B3H
Marzouk et al. Transplantation Research 2013, 2:8 Page 5 of 5
http://www.transplantationresearch.com/content/2/1/81V7, Canada. 2Department of Urology, Dalhousie University, Rm 294 5th
Victoria Building, Queen Elizabeth Health Sciences-VG site, 1276 South Park
Street, Halifax NS B3H 2Y9, Canada. 3Department of Urology, Dalhousie
University, Rm 5015 5th Floor Centennial Building, Queen Elizabeth Health
Sciences-VG site, 1276 South Park Street, Halifax NS B3H 2Y9, Canada.
4Department of Surgery, Dalhousie University, Rm 6302 6th Floor Centennial
Building, Queen Elizabeth Health Sciences-VG site. 1276 South Park Street,
Halifax NS B3H 2Y9, Canada.
Received: 12 March 2013 Accepted: 4 May 2013
Published: 15 May 2013References
1. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL: Delayed graft function:
risk factors and implications for renal allograft survival. Transplantation
1997, 63:968–974.
2. Lebranchu Y, Halimi JM, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V,
Oppenheimer F, Pohanka E, Salvadori M, Soergel M, Tufveson G, MOST
International Study Group: Delayed graft function: risk factors,
consequences and parameters affecting outcome-results from MOST.
A multinational observational study. Transplant Proc 2005, 37:345–347.
3. van der Vliet JA, Warlé MC, Cheung CL, Teerenstra S, Hoitsma AJ: Influence
of prolonged cold ischemia in renal transplantation. Clin Transplant 2011,
25:E612–E616.
4. Kayler LK, Srinivas TR, Schold JD: Influence of CIT-induced DGF on kidney
transplant outcomes. Am J Transplant 2011, 11:2657–2664.
5. Roodnat JI, Mulder PG, Van Riemsdijk IC, IJzermans JN, van Gelder T, Weimar
W: Ischemia times and donor serum creatinine in relation to renal graft
failure. Transplantation 2003, 75:799–804.
6. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC: A risk prediction
model for delayed graft function in the current era of deceased donor
renal transplantation. Am J Transplant 2010, 10:2279–2286.
7. Amit R, Patel AR, Eggener SE: Warm ischemia less than 30 minutes is not
necessarily safe during partial nephrectomy: every minute matters.
Urol Oncol-Semin O I 2011, 2:826–828.
8. Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi
F, Russo P, Stöckle M: Assessing the impact of ischaemia time during
partial nephrectomy. Eur Urol 2009, 56:625–634.
9. Hellegering J, Visser J, Kloke HJ, D’Ancona FC, Hoitsma AJ, van der Vliet JA,
Warlé MC: Deleterious influence of prolonged warm ischemia in living
donor kidney transplantation. Transplant Proc 2012, 44:1222–1226.
10. Grossberg JA, Reinert SE, Monaco AP, Morrissey P: Utility of a mathematical
normogram to predict delayed graft function: a single center
experience. Transplantation 2006, 81:155–159.
11. Moore J, Ramakrishna S, Tan K, Cockwell P, Eardley K, Little AM, Rylance P,
Shivakumar K, Suresh V, Tomlinson K, Ready A, Borrows R: Identification of
the optimal donor quality scoring system and measure of early renal
function in kidney transplantation. Transplantation 2009, 87:578–586.
12. Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP,
van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR,
Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ: Machine perfusion or
cold storage in deceased-donor kidney transplantation. N Engl J Med
2009, 360:7–19.
13. Dikdan GS, Mora-Esteves C, Koneru B: Review of randomized clinical trials
of donor management and organ preservation in deceased donors:
opportunities and issues. Transplantation 2012, 94:425–441.
14. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS,
Blute ML, Campbell SC: Every minute counts when the renal hilum is
clamped during partial nephrectomy. Eur Urol 2010, 58:340–345.
15. Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE: The severity of
acute kidney injury predicts progression to chronic kidney disease.
Kidney Int 2011, 79:1361–1369.
16. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney
injury. J Clin Invest 2011, 121:4210–4221.17. Barrera-Chimal J, Pérez-Villalva R, Rodríguez-Romo R, Reyna J, Uribe N,
Gamba G, Bobadilla NA: Spironolactone prevents chronic kidney disease
caused by ischemic acute kidney injury. Kidney Int 2013, 83:93–103.
18. Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E,
Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich
S, Feinstein E: siRNA targeted to p53 attenuates ischemic and cisplatin-
induced acute kidney injury. J Am Soc Nephrol 2009, 20:1754–1764.
doi:10.1186/2047-1440-2-8
Cite this article as: Marzouk et al.: The impact of vascular anastomosis
time on early kidney transplant outcomes. Transplantation Research 2013
2:8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
